Analysis
HTS 2933.29.45 covers other: drugs under heading 2933 (heterocyclic compounds with nitrogen hetero-atom(s) only).
Within this group the rate runs from duty-free to 6.5%. Compared with 2933.29.60 (other: imidazole), which pays duty-free, a misclassification either way moves the duty by 3.7 percentage points.
The general duty rate is 3.7% of the customs value, which is in the middle of the rates in chapter 29 (34th percentile of 1050 lines with an ad valorem rate). On a shipment valued at $10,000 that is $370 in duty before any Chapter 99 additions or preference claims.
Goods that qualify under GSP, the Australia FTA, the Bahrain FTA, the Chile FTA, the Colombia TPA, and 13 others can enter duty-free instead of paying 3.7%. It is also eligible under GSP, the developing-country programme, which Congress has to renew; check whether GSP is in force on the entry date.
The column 2 rate, for countries without normal trade relations, is 25%, 6.8 times the general rate.
Census statistics map these goods to NAICS 325411 (Medicinal and Botanical Manufacturing), an industry of 761 US establishments employing 30,382 people. That concordance is how imports of this line are compared with US output.
Neighbouring lines
| Line | Description | General rate |
|---|---|---|
| 2933.29.05 | 1-[1-((4-Chloro-2-(trifluoromethyl)phenyl)- imino)-2-propoxyethyl]-1H-imidazole (Triflumizole); and Ethylene thiourea | Free |
| 2933.29.10 | Aromatic or modified aromatic: 2-Phenylimidazole | 5.8% |
| 2933.29.20 | Other: drugs | 6% |
| 2933.29.35 | Products described in additional U.S. note 3 to section VI | 6.5% |
| 2933.29.43 | Other: other | 6.5% |
| 2933.29.60 | Other: imidazole | Free |
| 2933.29.90 | Other: other | 6.5% |